Trial Profile
An Open-Label, Drug-Drug Interaction Study Between Steady-State Valproic Acid and Single-Dose Paliperidone Extended-Release in Healthy Men.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Paliperidone (Primary) ; Valproate semisodium
- Indications Aggression; Bipolar disorders; Epilepsy; Insomnia; Manic episodes; Migraine; Schizoaffective disorder; Schizophrenia
- Focus Pharmacokinetics
- Sponsors Janssen Research & Development
- 28 Sep 2015 Results published in the Journal of Clinical Pharmacology.
- 08 Feb 2010 New trial record